| LINE ITEM (USD / %) | FY 2025
FILED 2026-05-31 | FY 2024
FILED 2025-05-31 | FY 2023
FILED 2024-05-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.38B | $1.15B | $1.25B |
| YoY Revenue Growth % | +19.7% | -7.4% | — |
| Gross Profit | $378.3M | $319.0M | — |
| Gross Margin % | 27.4% | 27.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $76.2M | -$10.7M | -$73.5M |
| Operating Margin % | 5.5% | -0.9% | -5.9% |
| Net Income (GAAP) | $156.1M | $96.1M | $110.6M |
| EBITDA (Normalized) | $120.9M | $29.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $226.1M | $209.7M | $290.0M |
| Capital Expenditures (CapEx) | $55.9M | $50.6M | — |
| Free Cash Flow (FCF) | $170.2M | $159.2M | $290.0M |
| FCF Margin % | 12.3% | 13.8% | 23.3% |
| Return on Invested Capital (ROIC %) | 5.5% | -0.8% | — |
| Cash & Short-Term Equivalents | $180.3M | $193.8M | — |
| Total Debt (Short + Long Term) | $305.3M | $295.7M | — |
| Total Stockholders' Equity | $962.6M | $911.3M | — |